• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC EUROPE SARL CONSULTA CRT-P; PULSE GENERATOR, PERMANENT, IMPLANTABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC EUROPE SARL CONSULTA CRT-P; PULSE GENERATOR, PERMANENT, IMPLANTABLE Back to Search Results
Model Number C4TR01
Medical Device Problem Code Pacing Problem (1439)
Health Effect - Clinical Code Bradycardia (1751)
Date of Event 01/28/2025
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that the patient had approximately ten seconds of sensed events below the cardiac resynchronization therapy defibrillator (crt-d) programmed lower rate.The crt-d remains in use.No further patient complications have been reported as a result of this event.
 
Additional Manufacturer Narrative
Continuation of d10: 419478 lead, implanted (b)(6) 2016.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Event or Problem Description
Additional information received noted that it was confirmed that the behavior was the result of the device feature that automatically monitors atrial pacing thresholds at periodic intervals test running with the right ventricular (rv) lead programmed subthreshold.
 
Additional Manufacturer Narrative
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Event or Problem Description
It was reported that the patient had approximately ten seconds of sensed events below the cardiac resynchronization therapy pacemaker (crt-p) programmed lower rate.The crt-p remains in use.Additional information received noted that it was confirmed that the behavior was the result of the device feature that automatically monitors atrial pacing thresholds at periodic intervals test running with the right ventricular (rv) lead programmed subthreshold.It was further reported that the crt-p device feature that automatically monitors atrial pacing thresholds at periodic intervals was programmed off.The crt-p remains in use.No further patient complications have been reported as a result of this event.
 
Additional Manufacturer Narrative
Correction: b5 medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CONSULTA CRT-P
Common Device Name
PULSE GENERATOR, PERMANENT, IMPLANTABLE
Manufacturer (Section D)
MEDTRONIC EUROPE SARL
route du molliau 31
case postale
tolochenaz vaud 1131
SZ  1131
Manufacturer (Section G)
MEDTRONIC EUROPE SARL
route du molliau 31
case postale
tolochenaz vaud 1131
SZ   1131
Manufacturer Contact
gerard torenvliet
8200 coral sea st ne
mounds view, MN 55112-4391
7635269277
MDR Report Key21367427
Report Number9614453-2025-00619
Device Sequence Number18263072
Product Code NVZ
UDI-Device Identifier00613994713667
UDI-Public00613994713667
Combination Product (Y/N)N
Initial Reporter StateMN
Initial Reporter CountryUS
PMA/510(K) Number
P010015
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2016
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Company Representative
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup,Followup
Report Date (Section B) 03/10/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Lay User/Patient
Device Expiration Date07/14/2017
Device Model NumberC4TR01
Device Catalogue NumberC4TR01
Was Device Available for Evaluation? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 01/28/2025
Supplement Date Received by Manufacturer02/13/2025
02/26/2025
Initial Report FDA Received Date02/12/2025
Supplement Report FDA Received Date02/26/2025
03/10/2025
Date Device Manufactured01/27/2016
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
5076-45 LEAD, 5076-52 LEAD
Patient SexMale
-
-